Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 37

1.

Demographics, tumor characteristics, treatment, and survival of patients with Klatskin tumors.

Sharma P, Yadav S.

Ann Gastroenterol. 2018 Mar-Apr;31(2):231-236. doi: 10.20524/aog.2018.0233. Epub 2018 Feb 8.

2.

Relationship of tumor size with pathological and prognostic factors for hilar cholangiocarcinoma.

Hu HJ, Zhou RX, Shrestha A, Tan YQ, Ma WJ, Yang Q, Lu J, Wang JK, Zhou Y, Li FY.

Oncotarget. 2017 Oct 23;8(62):105011-105019. doi: 10.18632/oncotarget.22054. eCollection 2017 Dec 1.

3.

Prognostic value of lymphovascular invasion in Bismuth-Corlette type IV hilar cholangiocarcinoma.

Li B, Xiong XZ, Zhou Y, Wu SJ, You Z, Lu J, Cheng NS.

World J Gastroenterol. 2017 Sep 28;23(36):6685-6693. doi: 10.3748/wjg.v23.i36.6685.

4.

Isolated IgG4-related sclerosing cholangitis misdiagnosed as malignancy in an area with endemic cholangiocarcinoma: a case report.

Rungsakulkij N, Sornmayura P, Tannaphai P.

BMC Surg. 2017 Feb 15;17(1):17. doi: 10.1186/s12893-017-0214-1.

5.

Development of a Risk Score to Predict Detection of Metastasized or Locally Advanced Perihilar Cholangiocarcinoma at Staging Laparoscopy.

Coelen RJ, Ruys AT, Wiggers JK, Nio CY, Verheij J, Gouma DJ, Besselink MG, Busch OR, van Gulik TM.

Ann Surg Oncol. 2016 Dec;23(Suppl 5):904-910. Epub 2016 Sep 1.

6.

Mucosa-associated lymphoid tissue (MALT) lymphoma as an unusual cause of malignant hilar biliary stricture: a case report with literature review.

Park YK, Choi JE, Jung WY, Song SK, Lee JI, Chung CW.

World J Surg Oncol. 2016 Jun 24;14(1):167. doi: 10.1186/s12957-016-0928-z. Review.

7.

Percutaneous vs. endoscopic pre-operative biliary drainage in hilar cholangiocarcinoma - a systematic review and meta-analysis.

Hameed A, Pang T, Chiou J, Pleass H, Lam V, Hollands M, Johnston E, Richardson A, Yuen L.

HPB (Oxford). 2016 May;18(5):400-10. doi: 10.1016/j.hpb.2016.03.002. Epub 2016 Apr 4. Review.

8.

Intraoperative frozen section analysis of the proximal bile ducts in hilar cholangiocarcinoma is of limited value.

Mantel HT, Westerkamp AC, Sieders E, Peeters PM, de Jong KP, Boer MT, de Kleine RH, Gouw AS, Porte RJ.

Cancer Med. 2016 Jul;5(7):1373-80. doi: 10.1002/cam4.693. Epub 2016 Apr 6.

9.

Diagnostic accuracy of staging laparoscopy for detecting metastasized or locally advanced perihilar cholangiocarcinoma: a systematic review and meta-analysis.

Coelen RJ, Ruys AT, Besselink MG, Busch OR, van Gulik TM.

Surg Endosc. 2016 Oct;30(10):4163-73. doi: 10.1007/s00464-016-4788-y. Epub 2016 Feb 19. Review.

10.

Combined portal vein resection for hilar cholangiocarcinoma.

Bai T, Chen J, Xie ZB, Ma L, Liu JJ, Zhu SL, Wu FX, Li LQ.

Int J Clin Exp Med. 2015 Nov 15;8(11):21044-52. eCollection 2015.

11.

A New Surgical Procedure "Dumbbell-Form Resection" for Selected Hilar Cholangiocarcinomas With Severe Jaundice: Comparison With Hemihepatectomy.

Wang S, Tian F, Zhao X, Li D, He Y, Li Z, Chen J.

Medicine (Baltimore). 2016 Jan;95(2):e2456. doi: 10.1097/MD.0000000000002456.

12.

Overexpression of Prdx1 in hilar cholangiocarcinoma: a predictor for recurrence and prognosis.

Zhou J, Shen W, He X, Qian J, Liu S, Yu G.

Int J Clin Exp Pathol. 2015 Sep 1;8(9):9863-74. eCollection 2015.

13.

Immune Adjuvant Activity of Pre-Resectional Radiofrequency Ablation Protects against Local and Systemic Recurrence in Aggressive Murine Colorectal Cancer.

Ito F, Ku AW, Bucsek MJ, Muhitch JB, Vardam-Kaur T, Kim M, Fisher DT, Camoriano M, Khoury T, Skitzki JJ, Gollnick SO, Evans SS.

PLoS One. 2015 Nov 23;10(11):e0143370. doi: 10.1371/journal.pone.0143370. eCollection 2015.

14.

Interleukin-8 is a prognostic indicator in human hilar cholangiocarcinoma.

Sun Q, Li F, Sun F, Niu J.

Int J Clin Exp Pathol. 2015 Jul 1;8(7):8376-84. eCollection 2015.

15.

Application of a Gastroduodenal Artery Graft for Reconstruction of the Hepatic Artery during Radical Resection of Hilar Cholangiocarcinoma.

Liang Y, Wang J, Shi X, Dong J, Gu W.

Gastroenterol Res Pract. 2015;2015:934565. doi: 10.1155/2015/934565. Epub 2015 Aug 3.

16.

Perioperative blood transfusion as a poor prognostic factor after aggressive surgical resection for hilar cholangiocarcinoma.

Kimura N, Toyoki Y, Ishido K, Kudo D, Yakoshi Y, Tsutsumi S, Miura T, Wakiya T, Hakamada K.

J Gastrointest Surg. 2015 May;19(5):866-79. doi: 10.1007/s11605-014-2741-8. Epub 2015 Jan 21.

17.

Laparoscopy in the management of hilar cholangiocarcinoma.

Cho A, Yamamoto H, Kainuma O, Muto Y, Yanagibashi H, Tonooka T, Masuda T.

World J Gastroenterol. 2014 Nov 7;20(41):15153-7. doi: 10.3748/wjg.v20.i41.15153. Review.

18.

Hilar cholangiocarcinoma: controversies on the extent of surgical resection aiming at cure.

Xiang S, Lau WY, Chen XP.

Int J Colorectal Dis. 2015 Feb;30(2):159-71. doi: 10.1007/s00384-014-2063-z. Epub 2014 Nov 8. Review.

19.

Perihilar cholangiocarcinoma: Current therapy.

Zhang W, Yan LN.

World J Gastrointest Pathophysiol. 2014 Aug 15;5(3):344-54. doi: 10.4291/wjgp.v5.i3.344. Review.

20.

Role of resection for Bismuth type IV hilar cholangiocarcinoma and analysis of determining factors for curative resection.

Han IW, Jang JY, Kang MJ, Kwon W, Park JW, Chang YR, Kim SW.

Ann Surg Treat Res. 2014 Aug;87(2):87-93. doi: 10.4174/astr.2014.87.2.87. Epub 2014 Jul 29.

Supplemental Content

Support Center